Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-01-31 | New | $3,275,000 | $3,275,000 | Equity Only | 06b | SEC link |
| 2024-07-24 | Amended | $15,875,000 | $13,250,000 | Debt Only | 06b | SEC link |
| 2022-10-20 | New | $2,625,000 | $2,625,000 | Debt Only | 06b | SEC link |
| 2022-03-04 | New | $37,731,621 | $37,731,621 | Equity Only | 06b | SEC link |
| 2021-07-07 | New | $5,520,000 | Unknown | Debt Only | SEC link | |
| 2020-09-28 | Amended | $3,250,000 | $500,000 | Equity Only | 06b | SEC link |
| 2020-05-13 | New | $2,750,000 | $2,750,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Mark Bamforth | Director |
| George Fotiades | Director |
| Mark Gilbert | Director |
| Matthew Haines | Executive |
| Derek Hennecke | Director |
| Sumiti Jain | Executive |
| David Michael Johnston | Director |
| Jason Lawrence | Executive |
| Abraham S. Maingi | Executive |
| Shailesh Maingi | Director |
| Michael Nicholson | Executive |
| Matthias Schroff | Director, Executive |
| Elizabeth Smith | Director |